The purpose of these studies was to determine whether lactogen-dependent Nb2-11c cells and lactogen-independent Nb2-SP cells differ with respect to morphology and autocrine growth control. To this end, the ultrastructural and surface morphology of both Nb2 cell lines was analyzed and the autocrine growth modulatory activity of Nb2 cell conditioned medium (Nb2-CM) was determined. The autocrine growth inhibitory activity of Nb2-CM was biologically characterized and attempts were made to biochemically characterize and purify the Nb2 cell autocrine growth inhibitor as well as to determine its mechanism of action. Quantitative analysis of transmission electron micrographs reveals that the ultrastructural morphology of lactogen-dependent Nb2-11c cells differs from that of lactogen-independent Nb2-SP cells. Nb2-11c cells exhibit a greater incidence and volume density of nuclear pockets, whereas the incidence and volume density of lipid droplets is greater in the Nb2-SP cell line. Surface feature of Nb2-11c and Nb2-SP cells, as examined with scanning electron microscopy, and indistinguishable. Nb2-11c and Nb2-SP cells share a common mode of growth control in the form of constitutive secretion of an autocrine inhibitory factor. Medium conditioned by either Nb2-11c or Nb2-SP cells inhibits the growth of both cell lines. Nb2-CM-mediated growth inhibition is dose-dependent and reversible. Nb2-CM does not induce quiescence or cell death, but rather, causes a delay in the progression of cells through all phases of the cell cycle. Nb2 cell proliferation stimulated by a variety of mitogens is inhibited by Nb2-CM. Nb2-CM also has the ability to inhibit the growth of normal rat splenocytes as well as MCF-7 human breast cancer cells. Biochemical analysis of Nb2-CM was equivocal; however, indirect evidence suggests that the autocrine growth inhibitory factor produced by Nb2 cells may be a prostaglandin or another arachadonic acid metabolite since the growth inhibitory activity of Nb2-CM is reduced when CM is prepared in the presence of indomethacin. Interestingly, levels of prostaglandin F₁(α) are elevated in CM-treated culture supernatants. Examination of other signal transduction systems in Nb2 cells suggests that neither cAMP activation, polyamine biosynthesis, nor protein kinase C activation mediate or influence the inhibitory effect of Nb2-CM.

The basis of this investigation is to characterize growth property differences in normal versus virally transformed cells. Using a temperature-sensitive mutant of Rous sarcoma virus, the cells' transformation state is regulated by the growth temperature; at 33°C the cells are transformed, while at 39°C the cells have normal characteristics. The morphology of NRK cells is elongated and fibroblastic; when transformed the cells are rounded. Normal cells grow to a monolayer and stop, while transformed cells grow to saturation densities greater than just a monolayer amount. Transformed cells can form foci when grown in mixture with normal cells. Normal cells must be in contact with the culture vessel in order to grow, but transformed cells lack anchorage dependence for growth.

In response to DNA damage, the ATM and ATR kinases proliferate a signal that is transduced, either directly or via Chk2 and Chk1, to effector proteins, forming the DNA damage response (DDR). The effector proteins delay cell cycle progression, through checkpoints, and activate specific DNA repair mechanisms essential for preserving genome integrity and preventing cancer formation. Bloom's syndrome (BS) patients, which lack the BLM protein show genome instability and have a predisposition to cancer. BLM is phosphorylated by the DDR kinases ATM, ATR and Chk1. These phosphorylation events are essential for BLM to maintain replication fork integrity, preserve the S phase checkpoint and activate BLM to interact with other DDR proteins. In this study I have shown that BLM, isolated from mitotic cells, is phosphorylated on amino acid residue serine 26 (S26). BS cells lacking native BLM, but expressing a variant of BLM protein that cannot be phosphorylated at S26, fail to fully activate the G2/M checkpoint following UV irradiation or treatment with inhibitors of DNA topoisomerase H. Consequently, these cells are more sensitive to killing by these agents than are BS cells expressing wildtype BLM. The Chk1 and Aurora B kinases are able to phosphorylate BLM on S26 in vitro. Moreover, loss of Aurora B kinase activity leads to reduction of S26 phosphorylation in mitotic cells. Cells treated with inhibitors of Aurora B fail to fully active the G2/M checkpoint after UV DNA damage. Taken together, these data suggest, that Aurora B kinase phosphorylates BLM on S26 and that this is required to fully activate the G2/M checkpoint.

In this thesis, we develop and apply top-down, quantitative approaches to gain novel insights into various complex biological systems. Beginning at the multicellular level, we study human gut microbiome dynamics from an ecological perspective. We develop computational frameworks to enable a global understanding of the spatiotemporal variability of gut bacterial abundances. We demonstrate the utility of our frameworks to elucidate the ecological processes governing abundance changes of gut microbiota. We then shift our focus to the intracellular level by investigating the metabolic limitations of cancer cell growth. We use coarse-grained mathematical modeling to identify a major growth limitation of cancer cells associated with electron acceptor deficiency, which we then experimentally validate. Collectively, these set of approaches help to decipher the organizing principles of complex biological systems at both the individual and multicellular levels.

Hepatoma-derived growth factor (HDGF) is commonly over-expressed in human cancer cells. It was able to stimulate cell growth. The expression level of HDGF was reported to correlate with poor prognosis of cancer therapy. It was found that HDGF is over-expressed in the fractionated gamma radiation conditioned HepG2 cells, which have higher growth rate, lower radiosensitivity and higher drug sensitivity. The aim of the present study was to investigate the role of HDGF in mediating these changes in human cancer cells and the underlying mechanisms. The results indicate that transfection of HDGF cDNA carrying vector stimulated the growth of cancer cells while knock-down of HDGF by transfection of HDGF antisense oligos not only suppressed the growth but also triggered apoptosis in human cancer cells. It suggests that HDGF stimulates cancer cell growth and acts as a survival factor for human cancer cells. Mechanistic study showed that knock-down of HDGF may trigger apoptosis through the regulation of the apoptotic pathways. The apoptosis induced by HDGF knock-down was mediated by the BAD regulated intrinsic apoptotic pathway and the Fas regulated extrinsic apoptotic pathway. The HDGF knock-down induced apoptosis was also mediated by the changes in the activity of the cell survival pathways, including the Ras/Raf/MEK/ERK, PI3K/Akt, NFkappaB and Jak/STAT pathways. In addition to the growth promoting function, HDGF was found to regulate the radiosensitivity and chemosensitivity of cancer cells. Overexpression of HDGF reduced the radiosensitivity and the level of apoptosis induced by gamma radiation. On the contrast, overexpression of HDGF increased the chemosensitivity and the level of apoptosis induced by anti-cancer drugs, including Taxol, doxorubicin (Dox) and tamoxifen. The results indicated that HDGF may stimulate the growth, reduce the radiation sensitivity and increase the drug sensitivity of cancer cells. HDGF may also be responsible for the changes in cancer cell properties after fractionated gamma radiation treatment. The present findings suggest that HDGF may be a potential target for cancer therapy. / Tsang, Tsun Yee. / Adviser: Tim Tak Kwok. / Source: Dissertation Abstracts International, Volume: 70-06, Section: B, page: 3497. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references. / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.

Orientador: Fernanda da Cruz Landim Alvarenga / Banca: Eunice Oba / Banca: Mateus José Sudano / Resumo: O sistema de cultivo in vitro de embriões apresenta menor eficiência em relação ao in vivo, sendo caracterizado por menores taxas de desenvolvimento e de adesão, além de uma menor tolerância à certas alterações que provocam estresse, como agentes físicos, químicos, térmicos, osmóticos, oxidativos, radioativos, entre outros. De acordo com a intensidade do estresse, pode-se estimular uma resposta celular favorecendo o desenvolvimento embrionário, adquirindo maior tolerância através de aceleração no metabolismo, proliferação e crescimento celular. O objetivo do presente trabalho foi analisar o efeito do estresse óptico em diferentes momentos ao longo do cultivo e conhecer as possíveis aplicações, a partir do estresse subletal e da bioestimulação promovida pela irradiação com diodo emissor de luz (LED). Com isto, os resultados demonstraram que em alguns estágios do desenvolvimento embrionário, tal como em blastocistos, o uso do estresse óptico pode ser benéfico ao embrião, protegendo-o de eventos como a apoptose. Os principais resultados demonstram que na produção de blastocistos houve aumento na produção dos mesmos nos grupos irradiados, apesar de não haver diferença estatística (Controle 23,2; IRD3inf 31,3; IRD6Infra 33,3). O estímulo por LED prévio à vitrificação mostrou que a irradiação por infravermelho em D3 pode estimular o aumento, em média, do numero de células (Controle: 91,9; IRD3inf: 112,8). Em relação às células apoptóticas, grupos irradiados com luz infravermelha mostraram menos número de células envolvidas neste processo (Controle: 11,6; IRD6inf: 6,6; IRFIVinf: 7,8), e a irradiação por luz vermelha pareceu aumentar a apoptose (IRD3verm: 15,6; IRD6verm: 16,1). Em relação à taxa de reexpansão, o a irradiação por luz vermelha teve efeito sobre o grupo irradiado em D3, mostrando uma diminuição significativa para o mesmo (Controle: 70,5 IRD3 verm; 39,3). De ... / Abstract: The in vitro embryo culture system has lower efficiency compared to in vivo, because the in vitro system is characterized by lower rates of development, deployment, and a lower tolerance to certain changes that cause stress, such as physical, chemical, thermal, osmotic, oxidative and radioactive among others. According to the stress intensity it is possible to stimulate a cellular response promoting embryonic development and acquiring greater tolerance by the acceleration of metabolism, cell proliferation and growth. The objective of this study was to analyze the effect of the optical stress at different periods throughout the embryo development and understand the possible applications for this stimulation, from sublethal stress and biostimulation promoted by irradiation with lasers. Therefore, the results showed that optical stress can be beneficial to the embryos at certain stages of their development, such as blastocysts stage, protecting them from apoptosis. The main results show that an increase in blastocysts production for infrared irradiated groups, although there was no statistical difference (control 23.2; IRD3inf 31.3; IRD6Inf 33.3). The infrared LED stimulus prior to vitrification showed a higher number of cells for embryos in D3 (control: 91.9; IRD3inf: 112.8). Also, infrared irradiation appeared to decrease the number of apoptotics cells, when compared to controls (control: 11.6; IRD6inf: 6.6; IRFIVinf: 7.8), and red light irradiation appeared to increase apoptosis (IRD3verm: 15.6; IRD6verm: 16.1). Regarding re-expansion rate, the red light irradiation in D3 is related a significant decrease in the rate (control: 70.5; IRD3verm: 39.3). According to the results, irradiation with infrared light effect is shown in blastocyst production, which is economically important to embryos IVP. Moreover, the apoptosis analysis showed that the association between the techniques applied in this study are important for the in ... / Mestre

Abstract not available

Errata slip inserted at back "August 2001." Includes bibliographical references (leaves 254-296)

Errata slip inserted at back / "August 2001." / Includes bibliographical references (leaves 254-296) / xxviii, 296, [9] leaves : charts (some col.), plates (some col.) ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Thesis (Ph.D.)--University of Adelaide, Dept. of Medicine, 2001

Lysophosphatidic acid (LPA) is a mitogenic lipid that enhances cell growth, proliferation and motility through binding and activation of at least four receptors, LPA1/Edg2, LPA2/Edg4, LPA3/Edg7, and PPAR and #947;. Here, we show that LPA stimulation inhibits the cell cycle regulator and tumor suppressor, p53. Ten M LPA reduced the cellular levels of total p53 and p53 phosphorylated at serine 15 by approximately 50% in A549 cells and this effect was sustained for at least 6 h. This resulted in a corresponding decrease in p53-mediated transcription. Transient-transfection of the Edg-family LPA receptors, LPA1-3 in HepG2 cells, which do not respond to LPA, also showed this inhibitory response. The response was specific to LPA receptors since neither Gi-coupled M2 muscarinic acetylcholine receptors, nor a mutant LPA1 receptor (LPA1 R124A), which is unable to bind LPA, inhibited p53 activity. Both transient-transfection of the LPA-degrading lipid phosphate phosphatase-1 (LPP-1), or exogenous addition of phospholipase B, which decreases exogenous lysophosphatidate, reversed the LPA receptor-induced decrease in p53-mediated transcription. Although pertussis toxin did not prevent the inhibition of p53, a mutant LPA1 receptor (LPA1 and #8710;361), which lacks the C-terminal PDZ-binding domain, failed to inhibit p53 function. This establishes LPA-mediated inhibition of p53 function requires an interaction with PDZ-containing proteins. These data establish a novel role for LPA-mediated receptor activation in diminishing p53 activity; which, in addition to LPAs well-characterized effects on growth-promoting signaling pathways, is likely to contribute to the survival and proliferation of cancer cells. Of the Edg-family LPA receptors, the LPA1 receptor is the most widely expressed. In the next study, we investigated the agonist-induced endocytosis of the human LPA1 receptor, bearing an N-terminal FLAG epitope tag, in stably transfected HeLa cells. LPA treatment induced the rapid endocytosis of approximately 40% of surface LPA1 within 15 minutes. Internalization was dose dependent and LPA specific since neither lysophophatidylcholine nor sphingosine-1-phosphate induced LPA1 endocytosis. Removing agonist following incubation resulted in LPA1 recycling back to the surface. LPA1 internalization was strongly inhibited by dominant-inhibitory mutants of both dynamin2 (K44A) and Rab5a (S34N). Finally, our results indicate that LPA1 exhibits basal, LPA-dependent internalization in the presence of serum-containing medium.